Table 2.
Baseline characteristics of the study population.
| Variable | Group A n = 39 |
Group B n = 31 |
Control n = 27 |
p |
|---|---|---|---|---|
| Age | 56.89 ± 9.12 | 55.83 ± 9.25 | 57.42 ± 12.29 | 0.744 |
| Gender female, n (%) | 34 (87.2) | 27 (87.1) | 23 (85.2) | 0.812 * |
| BMI (kg/m2) | 25.39 ± 3.23 | 24.76 ± 3.53 | 27.10 ± 3.31 | 0.052 |
| TC (mg/dL) | 259.8 ± 25.9 | 255.3 ± 25.1 | 247.0 ± 21.9 | 0.174 |
| LDL-C (mg/dL) | 167.7 ± 14.22 | 166.5 ± 14.31 | 162.2 ± 15.42 | 0.281 |
| HDL (mg/dL) | 64.12 ± 16.79 | 62.16 ± 14.69 | 56.65 ± 11.44 | 0.191 |
| TG (mg/dL) | 125.9 ± 73.5 | 132.3 ± 56.1 | 146.6 ± 51.4 | 0.062 |
| SGOT (U/L) | 26.71 ± 6.04 | 23.89 ± 6.52 | 24.52 ± 11.46 | 0.103 |
| SGPT (U/L) | 29.71 ± 6.20 | 25.53 ± 7.96 | 27.68 ± 13.37 | 0.102 |
| γ-GT (U/L) | 20.94 ± 6.88 | 17.56 ± 9.39 | 18.50 ± 10.66 | 0.105 |
| CPK (U/L) | 79.33 ± 25.17 | 88.42 ± 40.08 | 73.69 ± 30.74 | 0.165 |
Footnote: TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL: high-density lipoprotein cholesterol; TR: triglycerides; Sgpt: alanine transaminase; Sgot: aspartate transaminase; γ-gt: gamma-glutamyl transferase; CPK: creatine phosphokinase. Group A: 10 mg of monacolin; Group B: 3 mg of monacolin. p: one-way analysis of variance; p *: x2 test of independence. All values are expressed as the mean ± standard deviation.